Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-15

Clinical Trial Update: Efficacy and Safety of Interferon-Gamma Monoclonal Antibody Combined With Dexamethasone in the Treatment of Refractory Adult Secondary Hemophagocytic Lymphohistiocytosis

View source ↗

Summary

This completed clinical trial evaluated the efficacy and safety of combining an interferon-gamma monoclonal antibody with dexamethasone for adults with refracto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Emapalumab (emapalumab)

Snippet

Sponsor: Fudan University | Conditions: Adult Refractory Secondary Hemophagocytic Lymphohistiocytosis, Secondary Hemophagocytic Lymphohistiocytosis | Status: COMPLETED